John Kilcoyne

Mr. Kilcoyne is a proven leader in the medical device industry. He has broad and applicable experience leading high-tech medical device emerging growth organizations through market approvals, market access, high growth and successful strategic transactions, including IPOs and M&A activities. Currently Mr. Kilcoyne is the CEO of JenaValve a transcatheter aortic valve development company. Prior to JenaValve he served as President and CEO of ReVision Optics. From 2004 to 2010, he was President and CEO at Micrus Endovascular Corporation where he led an IPO in 2005, the capture of significant market share and, ultimately, the acquisition by Johnson & Johnson in 2010. He also held CEO positions at medical device companies Solace Therapeutics from 2002 to 2004 and Endonetics, which he joined in 1997 and was acquired by Medtronic in 2001. Mr. Kilcoyne also serves on the Board of Directors at Cerus Endovascular a start up device company focused on treating hemorrhagic stroke as well as the AdvaMed Board.